DarioHealth Corp. (DRIO): Price and Financial Metrics

DarioHealth Corp. (DRIO): $4.75

-0.07 (-1.45%)

POWR Rating

Component Grades














  • Growth is the dimension where DRIO ranks best; there it ranks ahead of 74.4% of US stocks.
  • DRIO's strongest trending metric is Stability; it's been moving up over the last 177 days.
  • DRIO ranks lowest in Momentum; there it ranks in the 1st percentile.

DRIO Stock Summary

  • With a year-over-year growth in debt of 6,900.84%, DARIOHEALTH CORP's debt growth rate surpasses 99.45% of about US stocks.
  • As for revenue growth, note that DRIO's revenue has grown 62.24% over the past 12 months; that beats the revenue growth of 86.1% of US companies in our set.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for DRIO comes in at -54.93% -- higher than that of merely 10.03% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to DARIOHEALTH CORP, a group of peers worth examining would be ZUO, INTA, LUCD, DOMO, and STXS.
  • DRIO's SEC filings can be seen here. And to visit DARIOHEALTH CORP's official web site, go to mydario.com.

DRIO Valuation Summary

  • DRIO's price/sales ratio is 4.2; this is 16% lower than that of the median Healthcare stock.
  • DRIO's price/earnings ratio has moved up 3.8 over the prior 116 months.

Below are key valuation metrics over time for DRIO.

Stock Date P/S P/B P/E EV/EBIT
DRIO 2022-12-02 4.2 1.3 -1.6 -1.2
DRIO 2022-12-01 4.2 1.3 -1.5 -1.1
DRIO 2022-11-30 4.3 1.3 -1.6 -1.2
DRIO 2022-11-29 4.3 1.3 -1.6 -1.2
DRIO 2022-11-28 4.2 1.3 -1.6 -1.2
DRIO 2022-11-25 4.3 1.3 -1.6 -1.2

DRIO Growth Metrics

    Its 3 year revenue growth rate is now at 216.97%.
  • Its 5 year net cashflow from operations growth rate is now at -94.33%.
  • Its 5 year net income to common stockholders growth rate is now at -129.88%.
Over the past 33 months, DRIO's revenue has gone up $19,316,000.

The table below shows DRIO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 26.875 -55.04 -73.025
2022-06-30 25.899 -56.78 -79.831
2022-03-31 24.977 -57.971 -79.623
2021-12-31 20.513 -50.409 -78.766
2021-09-30 16.565 -42.033 -66.359
2021-06-30 12.978 -33.39 -50.907

DRIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • DRIO has a Quality Grade of F, ranking ahead of 2.68% of graded US stocks.
  • DRIO's asset turnover comes in at 0.156 -- ranking 147th of 186 Medical Equipment stocks.
  • SPNE, ATRI, and ICAD are the stocks whose asset turnover ratios are most correlated with DRIO.

The table below shows DRIO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.156 0.284 28.266
2021-03-31 0.174 0.296 38.633
2020-12-31 0.266 0.332 847.338
2020-09-30 0.283 0.384 132.027
2020-06-30 0.404 0.439 -93.685
2020-03-31 0.426 0.403 -274.333

DRIO Price Target

For more insight on analysts targets of DRIO, see our DRIO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $27.53 Average Broker Recommendation 1.5 (Moderate Buy)

DRIO Stock Price Chart Interactive Chart >

Price chart for DRIO

DRIO Price/Volume Stats

Current price $4.75 52-week high $15.00
Prev. close $4.82 52-week low $3.66
Day low $4.51 Volume 107,400
Day high $4.84 Avg. volume 213,727
50-day MA $4.64 Dividend yield N/A
200-day MA $5.56 Market Cap 110.65M

DarioHealth Corp. (DRIO) Company Bio

DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Blood Glucose Monitoring System, a pocket-sized, blood glucose monitoring device. It offers DarioEngage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications; and real time alerts, trends, and pattern analysis. DarioHealth Corp. markets its products directly to consumer cash sales, as well as retail pharmacy, hospitals, and distributors; and through online. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel.

DRIO Latest News Stream

Event/Time News Detail
Loading, please wait...

DRIO Latest Social Stream

Loading social stream, please wait...

View Full DRIO Social Stream

Latest DRIO News From Around the Web

Below are the latest news stories about DARIOHEALTH CORP that investors may wish to consider to help them evaluate DRIO as an investment opportunity.

Two New Employers Join Dario Through Benefits Brokerage Partner

DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today that two employers selected Dario as part of an offering from a leading benefits brokerage partner that Dario had previously announced (the "Partner"). The employers will deploy Dario's solutions to help improve the cardiometabolic and musculoskeletal health of employees beginning in the first quarter of 2023.

Yahoo | December 1, 2022

The DarioHealth Corp. (DRIO) had a good session last reading, didn’t it?

In Tuesday’s session, DarioHealth Corp. (NASDAQ:DRIO) marked $4.91 per share, up from $3.92 in the previous session. While DarioHealth Corp. has overperformed by 25.26%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, DRIO fell by -70.60%, with highs and lows ranging from $17.29 to $3.66, whereas […]

US Post News | November 16, 2022

Dario to Participate in Craig-Hallum and BTIG Digital Health

DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today that management will participate at the following conferences:

Yahoo | November 16, 2022

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday''s Mid-Day Session

Gainers SenesTech, Inc. (NASDAQ: SNES ) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. Pineapple Energy Inc. (NASDAQ: PEGY ) shares jumped 45% to $3.41 after the company reported Q3 financial results. Siyata Mobile Inc. (NASDAQ: SYTA ) rose 37.2% to $0.2264 after jumping around 27% on Monday. Tenax Therapeutics, Inc. (NASDAQ: TENX ) gained 36% to $0.1262. Graphex Group Limited (NYSE: GRFX ) rose 33.4% to $1.39 after dropping over 5% on Monday. Energy Vault Holdings, Inc. (NYSE: NRGV ) surged 31% to $4.25. InMed Pharmaceuticals Inc. (NASDAQ: INM ) gained 30.5% to $3.63. InMed Pharmaceuticals recently posted a Q1 loss of $4.06 per share. Sea Limited (NYSE: SE ) shares gained 28.7% to $58.98 after the company reported better-than-expected Q3 results. Aze...

Benzinga | November 15, 2022

DarioHealth Corp. (DRIO) Q3 2022 Earnings Call Transcript

DarioHealth Corp. (NASDAQ:NASDAQ:DRIO) Q3 2022 Results Conference Call November 15, 2022 8:30 AM ET Company Participants Glenn Garmont - IR Erez Raphael - CEO Rick Anderson - President…

Seeking Alpha | November 15, 2022

Read More 'DRIO' Stories Here

DRIO Price Returns

1-mo 18.16%
3-mo 12.56%
6-mo -33.10%
1-year -67.06%
3-year -45.34%
5-year -84.06%
YTD -63.38%
2021 -9.24%
2020 117.84%
2019 -57.95%
2018 -51.25%
2017 -50.77%

Continue Researching DRIO

Want to see what other sources are saying about DarioHealth Corp's financials and stock price? Try the links below:

DarioHealth Corp (DRIO) Stock Price | Nasdaq
DarioHealth Corp (DRIO) Stock Quote, History and News - Yahoo Finance
DarioHealth Corp (DRIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7253 seconds.